Therapeutic Apheresis Market - 2024-2033
The Therapeutic Apheresis Market was valued at USD 2981.35 million in 2024 and is anticipated to reach USD 6009.58 million by 2033, at a CAGR of 0.085 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Therapeutic Apheresis Market.
This report delivers a comprehensive overview of the Therapeutic Apheresis Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Therapeutic Apheresis Market. The Therapeutic Apheresis Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.
Therapeutic Apheresis Market Scope:
By Procedure
This report delivers a comprehensive overview of the Therapeutic Apheresis Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Therapeutic Apheresis Market. The Therapeutic Apheresis Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Therapeutic Apheresis Market.
This report delivers a comprehensive overview of the Therapeutic Apheresis Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Therapeutic Apheresis Market. The Therapeutic Apheresis Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.
Therapeutic Apheresis Market Scope:
By Procedure
- Leukapheresis
- Plasmapheresis
- Plateletpheresis
- Erythrocytapheresis
- Others
- Hematology
- Neurology
- Oncology
- Nephrology
- Others
- Centrifugation
- Membrane filtration
- Blood banks
- Hospitals
- Specialty clinics
- Fresenius Kabi AG
- Asahi Kasei Medical Co.
- Haemonetics Corporation
- Cerus Corporation
- Terumo BCT Inc.
- B. Braun Melsungen AG
- Nikkiso Co. Ltd.
- Medica S.p.A.
- Kawasumi Laboratories Inc.
- Therakos Incorporation
This report delivers a comprehensive overview of the Therapeutic Apheresis Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Therapeutic Apheresis Market. The Therapeutic Apheresis Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
- Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
- South America (Colombia, Brazil, Argentina, Rest of South America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
- Increase Your Customer Base by 3X using our Partner Identification tool
- Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
- Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
- Prioritize partners by strategic fit rather than general capability.
- Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
- Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
- White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
- Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
- Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
- Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
1. METHODOLOGY AND SCOPE
1.1. Research methodology
1.2. Research Objective and Scope of the Report
2. MARKET DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Market Snippet by Service
3.2. Market Snippet by Procedure
3.3. Market Snippet by Technology
3.4. Market Snippet by Application
3.5. Market Snippet by End-user
3.6. Market Snippet by Region
4. MARKET DYNAMICS
4.1. Market Impacting Factors
4.2. Drivers
4.2.1. Rising demand for blood components across the globe
4.2.2. Increase in the government initiatives regarding blood donation
4.2.3. Driver
4.3. Restraints
4.3.1. Complications associated with apheresis procedures
4.3.2. Restraint
4.4. Opportunity
4.5. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Patent Analysis
6. COVID-19 ANALYSIS
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. BY PROCEDURE
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure Segment
7.1.2. Market Attractiveness Index, By Procedure Segment
7.2. Leukapheresis*
7.2.1. Introduction
7.2.2. Market Size Analysis, Y-o-Y Growth Analysis (%)
7.3. Plasmapheresis
7.4. Plateletpheresis
7.5. Erythrocytapheresis
7.6. Others
8. BY APPLICATION
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
8.1.2. Market Attractiveness Index, By Application Segment
8.2. Hematology*
8.2.1. Introduction
8.2.2. Market Size Analysis, Y-o-Y Growth Analysis (%)
8.3. Neurology
8.4. Oncology
8.5. Nephrology
8.6. Others
9. BY TECHNOLOGY
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology Segment
9.1.2. Market Attractiveness Index, By Technology Segment
9.2. Centrifugation*
9.2.1. Introduction
9.2.2. Market Size Analysis, Y-o-Y Growth Analysis (%)
9.3. Membrane filtration
10. BY END-USER
10.1. Introduction
10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user Segment
10.1.2. Market Attractiveness Index, By End-user Segment
10.2. Blood banks*
10.2.1. Introduction
10.2.2. Market Size Analysis, Y-o-Y Growth Analysis (%)
10.3. Hospitals
10.4. Specialty clinics
11. BY REGION
11.1. Introduction
11.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Countries
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Countries
11.3.7.1. Germany
11.3.7.2. U.K.
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Countries
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Countries
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia Pacific
11.6. The Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
12. COMPETITIVE LANDSCAPE
12.1. Competitive Scenario
12.2. Competitor Strategy Analysis
12.3. Comparative Procedure Portfolio Analysis
12.4. Market Positioning/Share Analysis
12.5. Mergers and Acquisitions Analysis
13. COMPANY PROFILES
13.1. Fresenius Kabi AG
13.1.1. Company overview
13.1.2. Procedure portfolio and description
13.1.3. Key highlights
13.1.4. Financial overview
13.2. Asahi Kasei Medical Co.
13.3. Haemonetics Corporation
13.4. Cerus Corporation
13.5. Terumo BCT Inc.
13.6. B. Braun Melsungen AG
13.7. Nikkiso Co. Ltd.
13.8. Medica S.p.A.
13.9. Kawasumi Laboratories Inc.
13.10. Therakos Incorporation
14. DATAM INTELLIGENCE
14.1. Appendix
14.2. About Us and Services
14.3. Contact Us
1.1. Research methodology
1.2. Research Objective and Scope of the Report
2. MARKET DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Market Snippet by Service
3.2. Market Snippet by Procedure
3.3. Market Snippet by Technology
3.4. Market Snippet by Application
3.5. Market Snippet by End-user
3.6. Market Snippet by Region
4. MARKET DYNAMICS
4.1. Market Impacting Factors
4.2. Drivers
4.2.1. Rising demand for blood components across the globe
4.2.2. Increase in the government initiatives regarding blood donation
4.2.3. Driver
4.3. Restraints
4.3.1. Complications associated with apheresis procedures
4.3.2. Restraint
4.4. Opportunity
4.5. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Patent Analysis
6. COVID-19 ANALYSIS
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. BY PROCEDURE
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure Segment
7.1.2. Market Attractiveness Index, By Procedure Segment
7.2. Leukapheresis*
7.2.1. Introduction
7.2.2. Market Size Analysis, Y-o-Y Growth Analysis (%)
7.3. Plasmapheresis
7.4. Plateletpheresis
7.5. Erythrocytapheresis
7.6. Others
8. BY APPLICATION
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
8.1.2. Market Attractiveness Index, By Application Segment
8.2. Hematology*
8.2.1. Introduction
8.2.2. Market Size Analysis, Y-o-Y Growth Analysis (%)
8.3. Neurology
8.4. Oncology
8.5. Nephrology
8.6. Others
9. BY TECHNOLOGY
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology Segment
9.1.2. Market Attractiveness Index, By Technology Segment
9.2. Centrifugation*
9.2.1. Introduction
9.2.2. Market Size Analysis, Y-o-Y Growth Analysis (%)
9.3. Membrane filtration
10. BY END-USER
10.1. Introduction
10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user Segment
10.1.2. Market Attractiveness Index, By End-user Segment
10.2. Blood banks*
10.2.1. Introduction
10.2.2. Market Size Analysis, Y-o-Y Growth Analysis (%)
10.3. Hospitals
10.4. Specialty clinics
11. BY REGION
11.1. Introduction
11.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Countries
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Countries
11.3.7.1. Germany
11.3.7.2. U.K.
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Countries
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Countries
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia Pacific
11.6. The Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
12. COMPETITIVE LANDSCAPE
12.1. Competitive Scenario
12.2. Competitor Strategy Analysis
12.3. Comparative Procedure Portfolio Analysis
12.4. Market Positioning/Share Analysis
12.5. Mergers and Acquisitions Analysis
13. COMPANY PROFILES
13.1. Fresenius Kabi AG
13.1.1. Company overview
13.1.2. Procedure portfolio and description
13.1.3. Key highlights
13.1.4. Financial overview
13.2. Asahi Kasei Medical Co.
13.3. Haemonetics Corporation
13.4. Cerus Corporation
13.5. Terumo BCT Inc.
13.6. B. Braun Melsungen AG
13.7. Nikkiso Co. Ltd.
13.8. Medica S.p.A.
13.9. Kawasumi Laboratories Inc.
13.10. Therakos Incorporation
14. DATAM INTELLIGENCE
14.1. Appendix
14.2. About Us and Services
14.3. Contact Us
